A detailed history of Bartlett & Co. Wealth Management LLC transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Bartlett & Co. Wealth Management LLC holds 1,333 shares of AADI stock, worth $3,999. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,333
Previous 1,333 -0.0%
Holding current value
$3,999
Previous $1.95 Million 41.11%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Feb 14, 2024

BUY
$12.03 - $14.22 $16,035 - $18,955
1,333 New
1,333 $18.8 Million

Others Institutions Holding AADI

About Aadi Bioscience, Inc.


  • Ticker AADI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,016,800
  • Market Cap $63.1M
  • Description
  • Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...
More about AADI
Track This Portfolio

Track Bartlett & Co. Wealth Management LLC Portfolio

Follow Bartlett & Co. Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bartlett & Co. Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bartlett & Co. Wealth Management LLC with notifications on news.